Financial insights of SDGR

MyFinsight

For the year ending 2025-12-31, SDGR made $255,869K in revenue. -$103,265K in net income. Net profit margin of -40.36%.

Income Statement	2025-12-31
Total revenues	255,869
Software Products And Services	51,001
Drug Discovery	62,254
Total cost of revenues	113,255
Gross profit	142,614
Research and development	173,138
Sales and marketing	40,963
General and administrative	95,409
Total operating expenses	309,510
Loss from operations	-166,896
Gain on equity investments	0
Change in fair value of equity investments	48,174
Other income	16,396
Total other income	64,570
(loss) income before income taxes	-102,326
Income taxes (benefit) at statutory federal rate	-21,489
State and local taxes, net of federal income tax effect	-47
Foreign tax effects, other foreign	-391
Other	151
General business credits	12,744
Changes in valuation allowance	30,813
Equity compensation	2,356
Section 162 officer's compensation	1,272
Other	543
Changes in unrecognized tax benefits	4,992
Transfer pricing	-3,457
Other, net	-1,060
Income tax expense	939
Net (loss) income	-103,265

Basic EPS	-1.41
Diluted EPS	-1.41
Basic Average Shares	73,443,298
Diluted Average Shares	73,443,298